adverse event info
search/sitemap
contact us
home
The Threat The Disease The Vaccine Education Toolkit Resource Center
Library Policies Released Vaccine Lots Forms Popular Resources Related Links Images Q&A
Commander Clinician Individual


 < BACK > BACK TO MAIN

 
title graphic  
 :: Pre-renovation BioPort Production :: Supplemental Testing Reports

Supplemental Testing Reports

Former Secretary of Defense Cohen ordered supplemental testing of all lots of anthrax vaccine in the Lansing, Michigan, original stockpile, when he authorized the Anthrax Vaccine Immunization Program in December 1997. Supplemental testing repeated the original FDA tests for sterility, purity, potency, and general safety. Supplemental tests were performed by the manufacturer and overseen by an independent contractor (Mitretek, Inc., McLean, Virginia). Supplemental tests are not performed on lots FAV 040 or higher, because these lots were not part of the original stockpile and subsequently, underwent (or will undergo) revised tests for sterility, purity, potency, and general safety and the data has been (or will be) independently reviewed by the FDA to determine whether the lots meet approval criteria for FDA release.






  HOME   THE THREAT THE DISEASE THE VACCINE EDUCATION TOOLKIT RESOURCE CENTER  
 
 
    adverse event info  what's new search/sitemap email sign up contact us  
 
 
Military Vaccine (MILVAX) Agency